2022
DOI: 10.1093/braincomms/fcac090
|View full text |Cite
|
Sign up to set email alerts
|

Dissecting central post-stroke pain: a controlled symptom-psychophysical characterization

Abstract: Central post-stroke pain affects up to 12% of stroke survivors and is notoriously refractory to treatment. However, stroke patients often suffer from other types of pain of non- neuropathic nature (musculoskeletal, inflammatory, complex regional) and no head-to-head comparison of their respective clinical and somatosensory profiles has been performed so far. We compared 39 patients with definite central neuropathic post-stroke pain with two matched- control groups: 32 patients with exclusively n… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
13
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

2
4

Authors

Journals

citations
Cited by 11 publications
(13 citation statements)
references
References 116 publications
0
13
0
Order By: Relevance
“…This cross-sectional study, part of the Central Pain Initiative Project, focused on assessing and treating CNP [10,18,19]. Here we aimed to compare the pain characteristics and sensory profile of CNP secondary to stroke to CNP secondary to spinal cord lesions in NMO.…”
Section: Me Thodsmentioning
confidence: 99%
See 4 more Smart Citations
“…This cross-sectional study, part of the Central Pain Initiative Project, focused on assessing and treating CNP [10,18,19]. Here we aimed to compare the pain characteristics and sensory profile of CNP secondary to stroke to CNP secondary to spinal cord lesions in NMO.…”
Section: Me Thodsmentioning
confidence: 99%
“…All participants were volunteers and provided written informed consent before inclusion. Some of the general clinical data of some included patients were reported in publications from this initiative [10,19]. All participants suffered an ischemic or hemorrhagic stroke confirmed by imaging (computed tomography or magnetic resonance imaging [MRI]) at least 3 months before the evaluation or had previous myelitis secondary to NMO diagnosed by a neuroinflammatory diseases specialist using the current diagnostic criteria [22].…”
Section: Standard Protocol Approvals and Patient Consentmentioning
confidence: 99%
See 3 more Smart Citations